Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
.065...05 X.10
VOLwatch /IMSU,
noted...135kVOL@.03 last, +15%
http://ih.advfn.com/p.php?pid=historical&symbol=imsu
Wayne Cockburn returns as CEO of iTech Medical brings BIO FLEX Merger to Table
iTech Management Updates the OTC Markets with Current Information
Good News on bio Flex Merger opportunity look at their website www.bioflexmagnets.com
News Out Today IMSU has a new team to go with the resurrected team IMSU will right the ship
Great News Today Bio Flex Acquisition read press release
HUNTINGTON BEACH, Calif., May 23, 2012 (GLOBE NEWSWIRE) -- iTech Medical, Inc. (Pink Sheet:IMSU) (FWB:0IM) and BIOflex Medical Magnetics, Inc. announced today that they have entered into a Letter of Intent under which iTech Medical will acquire 100% of BIOflex Medical Magnetics, a consumer healthcare company. BIOflex Medical Magnetics holds the exclusive worldwide rights to the patented BIOflex(R) magnetic therapy product line, developed specifically for human medical use. BIOflex Medical Magnetics is a pioneer in the practice of medical magnetic therapy with its 25 years of market leadership. The BIOflex(R) magnetic technology is founded on academic and clinical research demonstrating its ability to support the body's natural healing processes.
iTech Medical also announced today that Lee Brickey has been appointed Vice President, Business Development of the Company. Brickey, a successful entrepreneur with extensive knowledge of the magnetic therapy industry, brings more than 15 years of experience in building private and public companies.
"Our stated mission is to improve a person's health through the development and commercialization of innovative medical devices and healthcare information systems," said Wayne Cockburn, President of iTech Medical. "The BIOflex(R) magnetic therapy product line, with its strong academic and clinical reputation, meets this criteria and represents an excellent opportunity for iTech Medical to not only expand its product base, but it also allows us to begin generating product sales while we complete the final development and commercialization work on our Muscle Pattern Recognition technology. We are also very excited to welcome Mr. Brickey to iTech Medical. Lee's experience in building sales channels delivering multi-million dollar revenues will help iTech Medical as it expands into new and exciting healthcare product areas."
About iTech Medical - (Pink Sheet:IMSU) (FWB:0IM)
iTech Medical is engaged in the research and commercial development of healthcare information systems and technologies. To date, the Company has focused on developing a proprietary platform called Muscle Pattern Recognition (MPR), a unique clinical and rehabilitation tool for the analysis of muscle function.
For more information go to the iTech Medical website: www.iTechMedical.com or fact sheet, visit: http://premierstocks.tv/images/company_links/imsu.pdf
About BioFlex Medical Magnetics
BioFlex Medical Magnetics is engaged in the sale of the patented BIOflex(R) magnetic therapy product line. BIOflex(R) is the original magnet manufactured specifically and exclusively for human medical use. BIOflex(R) is an accepted form of therapy for use on sports injuries and chronic pain conditions including tendonitis, wrist and elbow pain, sprains and strains and chronic lower back pain. BIOflex(R) Concentric Circle Magnets have been clinically tested at a number of prestigious institutions including the University of Kentucky, University of Tennessee and the Baylor College of Medicine.
For further information, visit the BIOflex Medical Magnetic Systems website: www.bioflexmagnets.com
Forward-Looking and Cautionary Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that reflect management's current views and estimates regarding future market conditions, company performance and financial results, business prospects, new strategies, the competitive environment and other events. You can identify these statements by the fact that they use words such as "anticipate," "believe," "estimate," "expect," "intend," "project," "plan," "outlook," and other words and terms of similar meaning.
These statements involve a number of risks and uncertainties that could cause actual results to materially differ from the potential results discussed in the forward-looking statements. Among the factors that could cause actual results and outcomes to differ materially from those contained in such forward-looking statements are the following: general economic conditions, acquisitions and development of new businesses, divestitures, product availability, sales volumes, pricing actions and promotional activities of our competitors, profit margins, weather, changes in law or regulations, foreign currency fluctuation, availability of suitable real estate locations, our ability to react to a disaster recovery situation, and the impact of labor markets and new product introductions on our overall profitability.
iTech Medical cautions that the foregoing list of important factors is not complete and assumes no obligation to update any forward-looking statements that it may make. All such forward-looking statements are current only as of the date on which such statements were made. iTech Medical, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
Contact:
Investor Relations
WallStreet Media Group
Bryan Andrew
bryan@wallstreetmediagroup.com
Office: 480.588-8658 or 866.465-6551
iTech Medical, Inc.
Wayne Cockburn
Huntington Beach, CA
714.841.2670
Montreal, CDA
905.505.0770
Wayne.Cockburn@iTechMedical.com
Activity on IMSU stock for past two trading days
OTC MARKETS Look Out I hear they are finally going back on the board to begin trading again
iTech Medical Shareholders Restructure the Board of Directors
| 10:04 AM |
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=69149681
Nice volume day with a lot of buys all of a sudden
That's why I wanted to moderate the board, because I think it has long term potential. Goodluck
need to turn up the volume, this one needs some buzz to wake it up!! has vast potential. IMO
I'm in at .57 cents. I feel this will go over a dollar but it may be a bit until it does
Anyone in this stock? I've been holding on for awhile at a high price...
Closed at a very high volume relative to this week. Hopefully we see green soon!
I think our ibox is needing some love
Penny Stock Chaser has been a great promoter. I've seen many stocks follow their lead
hey, forget this guy?
just kidding!
have a nice one...just read a post by PennyChaser
Keith
Hopefully it goes to $2 like Penny Stock Chaser is predicting
Math
Were alone here but making good money !
Picked up 10 k here, volume coming in.
Followers
|
4
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
80
|
Created
|
10/19/08
|
Type
|
Free
|
Moderators |
CORPORATE HEADQUARTERS
iTech Medical Inc.
17011 Beach Boulevard, Suite 900
Huntington Beach, CA 92647
TEL: 714-841-2670
FAX: 714-841-2720
Email: wayne.cockburn@iTechMedical.com
Website: www.itechmedical.com
OTC: IMSU- FWB: OIM
The Company
iTech Medical, Inc. is a public medical technology company. Our first product is a medical device called Muscle Pattern Recognition (MPR), a unique testing system that objectively and quantitatively measures the biomechanical dysfunctions associated with musculoskeletal injuries of the back and the neck.
Message from the President
iTech Medical (OTCBB: IMSU) was established in 2003 as a medical technology company. Since that time, we have been engaged in the research and commercial development of a unique healthcare information system called Muscle Pattern Recognition (MPR).
Our goal, however was to build a company with more than one product. We set out to build a company that would, over time, develop a diversified portfolio of superior and innovative products that would improve people's health. In pursuit of this goal, we recently signed a Letter of Intent to acquire BIOflex Medical Magnetics, a pioneer in the practice of medical magnetic therapy.
The BIOflex magnetic technology is founded on academic and clinical research demonstrating its ability to support the body's natural healing processes.
We are very excited about this development and even more excited about the possible synergies between the two business. The acquisition of BIOflex Medical Magnetics is an important step in the evolution of iTech Medical and we invite you to follow our progress in the year ahead.
Thank you for your interest in iTech Medical and for taking the time to visit our web site. For more information on our company, please send an email to: wayne.cockburn@iTechMedical.com
Board of Directors - Management Team
Wayne Cockburn, CEO, Director - Mr. Cockburn joined iTech Medical (IMSU) in September 2003. Prior to IMSU, Mr. Cockburn was President at MPR Health Systems from January 2002 until September 2003 and Executive Vice President from January 2000 until January 2002. From January 1995 to December 1999, Mr. Cockburn was Vice President, Business Development for Lorus Therapeutics, a public biotechnology company. Mr. Cockburn's background includes strategic planning, corporate finance, corporate partnering, corporate governance and mergers and acquisitions
Alan J. Goldman, M.D, Vice President Clinical and Medical Affairs - Dr. Goldman joined iTech Medical (IMSU) in September 2003. Prior to joining IMSU, Dr. Goldman was a practicing Board Certified neurologist for over 27 years and an Associate Clinical Professor of Neurology at the University of California (Irvine). Through his practice, Dr. Goldman attained extensive experience with work-related injuries. He served as a neurology consultant to numerous insurers and served for four years on the Medical Advisory Board of Blue Cross.
Dr. Goldman serves as an expert witness in Workers' Compensation and general liability litigation matters and was recently appointed as a Medical Panel Chairperson for the State of Utah Labor Commission. His Workers Compensation appointments include Independent Medical Examiner for the State of California in 1990, Qualified Medical Evaluator, State of California in 1991 and Agreed Medical Evaluator, State of California in 1992. Dr. Goldman is also a member of the American Academy of Neurology, the California Medical Association, the Utah Medical Association and a Past-President of the Orange County Neurological Society. At IMSU, Dr. Goldman is responsible for all the clinical and medical affairs of the Company. In addition to being a key member of the management team, Dr. Goldman also serves as Chairman of the Company's Medical Advisory Board.
Kenneth Aebi. Director - Mr. Aebi has more than 40 years experience as a successful sales and management executive in emerging medical technology companies. Mr. Aebi has an extensive track record in successful new business development, product sales and positioning strategies, management of national teams of sales representatives and corporate partnering. Mr. Aebi was a Vice President at MPR Health Systems, the company that developed the early MPR System. Mr. Aebi served for 11 years as Vice President, Sales for NeuroCom International, a manufacturer of technology for the assessment and management of patients with vestibular and balance disorders. Since 2005, Mr. Aebi has served as the managing partner in the Equitable Safety Group Inc., a consulting group that specializes in the development of business plans for individual medical centers as well as national hospital groups, to reduce medical injuries.
Craig Lunsman. Director - Mr. Lunsman is the President of William Jamieson Group, Inc., a consulting group that provides securities valuation and corporate advisory services to public and private small cap companies, since he founded the company in 1993. Prior to that, Mr. Lunsman was a co-founder and principal in Houlihan Valuation Advisors, Inc., a company specializing in providing services related to business valuations, fairness opinions and other valuation and economic issues. Mr. Lunsman received his BS from the University of Southern California in 1970 and graduate work for his MBA and has been involved in providing strategic planning, financing and other corporate advisory services since that time. He has served as an Expert Witness on business valuation and other related financial matters in California and other states, and has also testified before the Internal Revenue Service relative to valuation matters. He has been a member of the American Society of Appraisers, San Francisco Chapter and has been a published author and a frequent speaker on issues relating to business valuation. Mr. Lunsman was a member of iTech Medical's board from 2007 until 2011 where he acted as Chairman of the Company's Audit Committee as well as serve on each of the Compensation and Corporate Governance Committees.
Patricia Colvin, Director of Operations and Financial Controller - Ms. Colvin joined iTech Medical (IMSU) in September 2003 and is responsible for Operations and Human Resources for the Company. Ms. Colvin is also responsible for Quality Control for the Muscle Pattern Recognition technology, including the development and implementation of policies and procedures for software development, hardware assembly, material outsourcing and training and certification of Technicians and Trainers. Prior to joining IMSU, Ms. Colvin was Director of Operations and Human Resources at MPR Health Systems from February 1997 until August 2003.
CORPORATE HEADQUARTERS
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |